(VIANEWS) - OceanFirst Financial Corp. (OCFC), Enterprise Products (EPD), Quanex Building Products Corporation (NX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OceanFirst Financial Corp. (OCFC)
31.1% sales growth and 7.64% return on equity
OceanFirst Financial Corp. is the bank holding firm for OceanFirst Bank N.A. It provides banking services to the community. The bank accepts time deposits for retail and government customers. It also provides commercial real estate and multi-family land, commercial, industrial, construction and interest-bearing checking accounts; fixed-rate or adjustable-rate home loans secured by up to four family homes; as well as consumer loans such as student loans, lines of credit, home equity loans and line of credit, loan on savings, loans on bank accounts and loans for other consumers. It also invests in U.S. Government securities and corporate securities. The company also offers wealth management and bankcard services, as well as trust and asset management and alternative investment products. It operated from its Toms River branch; an administrative office is located in Red Bank, Mount Laurel, 46 other branch offices, four deposit production centers, as well as commercial loan production offices throughout New Jersey, New York City and the Philadelphia region, Baltimore and Boston. Red Bank is the home of the company, which was established in 1902.
Earnings per Share
OceanFirst Financial Corp.'s trailing 12 months EPS is $1.27.
PE Ratio
OceanFirst Financial Corp.'s trailing 12-month price-to-earnings ratio is 18.55. The purchaser of the shares is therefore investing $18.55 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 7.64%.Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be made on November 3, 2022. The forward dividend rate for the year is estimated at 0.8, and the forward dividend yield to be 3.72%.
Annual Top and Bottom Value
At 15:22 EST OceanFirst Financial Corp. stock was valued at $23.65, which is below its 52 week high of $24.25 but well above its low 52-week of $18.24.
2. Enterprise Products (EPD)
30.3% sales growth and 18.96% return on equity
Enterprise Products Partners L.P. offers midstream energy services for natural gas producers, consumers, crude oil, petrochemicals and refiners. NGL Pipelines & Services; Crude Oil Pipelines & Services; Natural Gas Pipelines & Services; Petrochemical & Refined Products Services. NGL Pipelines & Services offers natural gas processing as well as related NGL marketing service. The company operates natural gas processing plants in Colorado, Louisiana and Mississippi as well as Texas, New Mexico and Texas. It also has NGL pipelines, NGL fractionation and NGL storage facilities. Crude Oil Pipelines & Services operates crude oil pipelines and crude oil storage. It also manages NGL fractionation facilities, crude oil storage terminals and NGL marine terminals. This segment includes 255 tractor-trailer truck tank trucks used for crude oil transportation. The company also participates in crude oil marketing. Natural Gas Pipelines & Services operates natural gas pipelines to transport, treat and gather natural gas. The company leases underground natural gas storage units in Napoleonville, Louisiana, and owns an underground storage cavern for salt domes in Wharton County in Texas. It also markets natural gas. Petrochemical & Refined Products Services operates the following segments: propylene fractionation, related marketing activities; butane Isomerization Complex and associated deisobutanizer operation; and octane enhance and high purity isobutylene manufacturing facilities. The company also manages refined product terminals and refinements; ethylene export terminals; as well as providing marine transport services and refined products marketing. Houston is the headquarters of this company, which was established in 1968.
Earnings Per Share
As for profitability, Enterprise Products has a trailing twelve months EPS of $1.71.
PE Ratio
Enterprise Products has a trailing twelve months price to earnings ratio of 14.58. Meaning, the purchaser of the share is investing $14.58 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.96%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 19.2% and 34% respectively.Moving Average
Enterprise Products's worth is above its 50-day moving average of $24.97 and below its 200-day moving average of $25.57.Sales Growth
Enterprise Products is forecast to grow at 30.3% in the fourth quarter.
Revenue Growth
Year-on-year quarterly revenue growth grew by 69.9%, now sitting on 51.27B for the twelve trailing months.
3. Quanex Building Products Corporation (NX)
21.4% sales growth and 19.77% return on equity
Quanex Building Products Corporation, together with its subsidiaries, provides components for the fenestration industry worldwide. It operates through three segments: North American Fenestration, European Fenestration, and North American Cabinet Components. The company offers flexible insulating glass spacers, extruded vinyl profiles, window and door screens, and precision-formed metal and wood products, as well as cabinet doors and other components for original equipment manufacturers (OEMs) in the kitchen and bathroom cabinet industry. It also provides various non-fenestration components and products, including solar panel sealants, trim moldings, vinyl decking, fencing, water retention barriers, and conservatory roof components. The company sells its products to OEMs in the building products industry through sales representatives, direct sales force, distributors, and independent sales agents. Quanex Building Products Corporation was founded in 1927 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Quanex Building Products Corporation has a trailing twelve months EPS of $2.53.
PE Ratio
Quanex Building Products Corporation has a trailing twelve months price to earnings ratio of 8.69. Meaning, the purchaser of the share is investing $8.69 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.77%.Volume
Today's last reported volume for Quanex Building Products Corporation is 109006 which is 24.7% below its average volume of 144775.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Quanex Building Products Corporation's EBITDA is 20.54.
Annual Top and Bottom Value
Quanex Building Products Corporation stock was valued at $21.99 as of 15:22 EST. This is way lower than the 52-week high at $25.94, and much higher than its low 52-week of $18.00.
4. Autodesk (ADSK)
9.7% sales growth and 53.97% return on equity
Autodesk, Inc. offers 3D engineering, entertainment, and design software worldwide. AutoCAD Civil 3D is a 3D design and engineering software and services company. It offers Inventor software that allows for 3D mechanical designs, simulations, analysis, tooling visualization and documentation. Vault is a data management program to store data centrally, speed up design processes and reduce collaboration. Maya and 3ds Max products offer 3D modeling and animation. ShotGrid can be used for production monitoring and review in media and entertainment. The company sells products and services directly to its customers as well as via a network distributors and resellers. Autodesk, Inc., was founded in 1982. It is located in San Rafael, California.
Earnings per Share
Autodesk's trailing 12 months profit per share is $5.44
PE Ratio
Autodesk's trailing 12 months earnings to price ratio is 38.48. The purchaser of the shares is therefore investing $38.48 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 53.97%.Yearly Top and Bottom Value
Autodesk's stock is valued at $209.32 at 15:22 EST, way below its 52-week high of $325.21 and way higher than its 52-week low of $163.20.
Revenue growth
The year-on-year revenue growth was 16.7%. We now have 4.74B in the 12 trailing months.
5. Stryker Corp (SYK)
7.3% sales growth and 14.1% return on equity
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Earnings Per Share
As for profitability, Stryker Corp has a trailing twelve months EPS of $3.69.
PE Ratio
Stryker Corp has a trailing twelve months price to earnings ratio of 61.4. Meaning, the purchaser of the share is investing $61.4 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.1%.6. Greif (GEF)
7% sales growth and 24.47% return on equity
Greif, Inc. manufactures and distributes worldwide industrial packaging products. The company operates in four main segments: Rigid Industrial Packaging & Services, Paper Packaging & Services, Flexible Products & Services and Land Management. Rigid Industrial packaging & services offers rigid products such as steel, fiber and plastic drums, rigid intermediate bulk containers, closure systems for industrial packing products, transit protection products, water bottles and remanufactured or reconditioned industrial containers. It also provides services like container lifecycle management, filling logistics, warehousing and other packaging services. The segment offers its products to chemical, pharmaceutical, mineral, food, beverage and other industries. Paper Packaging & Services provides corrugated sheet, containerboards and corrugated containers to customers in packaging, food and building product industries. The segment's Corrugated Container Products are used for shipping various items, including home appliances, small machines, groceries, automobile components, books and furniture. Flexible Products and Services offers intermediate bulk containers that are flexible. They include polypropylene-based, woven fabrics, as well related services for the food, agricultural, and other industries. Land Management is involved in the harvesting, regeneration and sale timberland. This segment had approximately 251,000 acres in timber land located in the southeast United States as of October 31, 2019. Greif Bros was the company's former name. Greif, Inc. was established in 2001. Greif, Inc. was established in Delaware, Ohio in 1877.
Earnings per Share
Greif's trailing 12 month EPS is $2.06.
PE Ratio
Greif's trailing 12-month price-to-earnings ratio is 34.19. The purchaser of the shares is therefore investing $34.19 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a business relative shareholder equity, was 24.47%.Yearly Top and Bottom Value
Greif's stock is valued at $70.50 at 15:22 EST, under its 52-week high of $73.79 and way higher than its 52-week low of $53.65.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 1.6% and 15.6%, respectively.7. ICON plc (ICLR)
5.1% sales growth and 5.73% return on equity
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Earnings per Share
ICON plc's trailing 12 months profit per share is $5.6
PE Ratio
ICON plc's trailing 12-month price-earnings ratio is 35.14. The purchaser of the shares is buying $35.14 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 5.73%.